BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33774690)

  • 1. The Relationship Between Co-morbidity, Screen-Detection and Outcome in Patients Undergoing Resection for Colorectal Cancer.
    Johnstone MS; McMillan DC; Horgan PG; Mansouri D
    World J Surg; 2021 Jul; 45(7):2251-2260. PubMed ID: 33774690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer.
    Johnstone MS; McSorley ST; McMillan DC; Horgan PG; Mansouri D
    Colorectal Dis; 2024 Jan; 26(1):81-94. PubMed ID: 38095280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less Invasive Primary Treatment for Colorectal Cancer After Implementation of National Screening: A Nationwide Cohort Study.
    Dressler J; Njor SH; Jørgensen LN; Rasmussen M
    World J Surg; 2023 Nov; 47(11):2877-2887. PubMed ID: 37610467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
    Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
    Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
    Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
    Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
    Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.
    Shin JS; Suh KW; Oh SY
    J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis.
    Li H; Zhao Y; Zheng F
    Medicine (Baltimore); 2019 Jan; 98(3):e14126. PubMed ID: 30653142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients.
    Spolverato G; Capelli G; Battagello J; Barina A; Nordio S; Finotti E; Mondi I; Da Lio C; Morpurgo E; Navarro JA; Ceccato F; Perin A; Pedrazzani C; Turri G; Zanus G; Campi M; Massani M; Di Giacomo A; Prando D; Agresta F; Pucciarelli S; Zorzi M; Rugge M
    Front Oncol; 2021; 11():620644. PubMed ID: 33791207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
    Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
    Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.
    Mansouri D; Powell AG; Park JH; McMillan DC; Horgan PG
    World J Surg; 2016 Jun; 40(6):1485-91. PubMed ID: 26920405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery.
    Malietzis G; Giacometti M; Askari A; Nachiappan S; Kennedy RH; Faiz OD; Aziz O; Jenkins JT
    Ann Surg; 2014 Aug; 260(2):287-92. PubMed ID: 24096764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of systemic inflammatory response in stage II colorectal cancer.
    Oh SY; Kim YB; Suh KW
    J Surg Res; 2017 Feb; 208():158-165. PubMed ID: 27993203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
    Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
    Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.